Volume 26, Number 2—February 2020
Novel Subclone of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 with Enhanced Virulence and Transmissibility, China
|Variable||p value†||OR (95% CI)|
|Platelets at time of BSI
|APACHE II score at time of BSI
|Tigecycline as empirical therapy||0.003||1.920 (1.257–2.935)|
*APACHE, Acute Physiology and Chronic Health Evaluation; BSI, bloodstream infection; OR, odds ratio.
†Calculated by using Cox regression.
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.